Stockscreener 앱 받기
161.64
0.65%
-1.05
시간 외 거래:
163.63
1.99
+1.23%
전일 마감가:
$162.69
열려 있는:
$161.34
하루 거래량:
1.42M
Relative Volume:
0.78
시가총액:
$9.09B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-3.31%
1개월 성능:
-8.35%
6개월 성능:
+14.12%
1년 성능:
+19.46%
1일 변동 폭
$159.68
$162.38
1주일 범위
$159.68
$166.81
52주 변동 폭
$107.43
$179.64
Ishares Biotechnology Etf Stock (IBB) Company Profile
Compare IBB vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IBB
Ishares Biotechnology Etf
|
161.64 | 9.09B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
323.18 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
State Street Spdr S P 500 Etf Trust
|
653.18 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
656.23 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
263.51 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
583.98 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Biotechnology Etf 주식(IBB)의 최신 뉴스
DAFNA Capital Sells iShares Biotech ETF Shares: Portfolio Impact & ETF FocusNews and Statistics - IndexBox
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing - AOL.com
DAFNA Capital Reduces Holdings in iShares Biotechnology ETF as Part of Overall Biotech Portfolio Adjustment, Recent SEC Filing Shows - Bitget
iShares NASDAQ Biotechnology ETF declares quarterly distribution of $0.1218 - MSN
Clearance etf indice biotecnologie nasdaq Deals Como operar com o indice NASDAQ Investimento em NASDAQ LiteFinance - маяк32.рф
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. - The Motley Fool
iShares Biotechnology ETF Estimated Cash Index OverviewStock Price, Quote and News - marketscreener.com
Bank of America Corp DE Lowers Holdings in iShares Biotechnology ETF $IBB - Defense World
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave - TradingView
Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes - Benzinga
SOXXBlackRock Announces Product Updates to Two iShares ETFs - mx.advfn.com
Aster Capital Management DIFC Ltd Makes New Investment in iShares Biotechnology ETF $IBB - Defense World
iShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.0828 - MSN
7 Best Healthcare ETFs for Long-Term Investors - Coinpaper
How to Buy iShares Biotechnology ETF (IBB) - The Motley Fool
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - Yahoo Finance
Merit Financial Group LLC Trims Stock Holdings in iShares Biotechnology ETF $IBB - Defense World
Caprock Group LLC Takes Position in iShares Biotechnology ETF $IBB - Defense World
XBI vs. IBB: Which Biotech ETF do Analysts Prefer in 2026? - TipRanks
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
Top ETFs Tracking CRISPR Gene Editing for 2026 - The Motley Fool
Reasons the Biotech Sector Might Be Shifting and the Implications of the iShares Biotechnology ETF (IBB) - Intellectia AI
Biotech in Flux: Patent Cliff and IPO Revival Shape the IBB - AD HOC NEWS
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - US News Money
Biotech ETF Recommended, Amcor Reports Strong Earnings - Intellectia AI
Best Biotech ETFs to Buy in 2026 - The Motley Fool
Amcor, Emerson Electric And More: CNBC's 'Final Trades' - Benzinga
Biotechnology Sector Faces Headwinds as Key ETF Navigates Challenges - AD HOC NEWS
6 Best Health Care Funds and ETFs to Buy Now - US News Money
Florin Court Capital LLP Makes New Investment in iShares Biotechnology ETF $IBB - Defense World
This Wealth Manager Just Dumped Its Entire $3.5 Million Stake in the iShares Biotech ETF - AOL.com
IBB: Beyond The 2025 Surge, Biotech Breakout (NASDAQ:IBB) - Seeking Alpha
IBB: Biotech's Hot Streak May Cool (NASDAQ:IBB) - Seeking Alpha
2 Under-the-Radar Biotech Stocks Set to Boom in 2026 - The Motley Fool
Health Care Stocks Steady, iShares Biotechnology ETF Inactive - Intellectia AI
Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026 - 24/7 Wall St.
Nvidia–Eli Lilly Tie-Up Shows Why AI Drug Discovery Is The Next ETF Battleground - Benzinga
SG Americas Securities LLC Has $4.13 Million Stock Position in iShares Biotechnology ETF $IBB - Defense World
A Tale of Two Biotechs: Stability and Speculation in the ETF Arena - AD HOC NEWS
D.A. Davidson & CO. Increases Stock Position in iShares Biotechnology ETF $IBB - Defense World
Here's Why Biotech ETFs Are Rallying Hard - Yahoo Finance
Head-To-Head Survey: iShares Biotechnology ETF (NASDAQ:IBB) vs. Nuveen New York Municipal Valu (NYSE:NNY) - Defense World
As AI Valuations Stretch, Health Care ETFs Step Into The Growth Spotlight - Benzinga
Ishares Biotechnology Etf (IBB) 재무 분석
Ishares Biotechnology Etf (IBB)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.55%
1.16%
자본화:
|
볼륨(24시간):